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RESEARCH ARTICLE

Open Access

Motor neuron apoptosis and neuromuscular
junction perturbation are prominent features
in a Drosophila model of Fus-mediated ALS
Ruohan Xia1, Yajuan Liu1, Liuqing Yang2, Jozsef Gal2, Haining Zhu2* and Jianhang Jia1,2*

Abstract
Backgound: Amyotrophic lateral sclerosis (ALS) is progressive neurodegenerative disease characterized by the loss
of motor function. Several ALS genes have been identified as their mutations can lead to familial ALS, including
the recently reported RNA-binding protein fused in sarcoma (Fus). However, it is not clear how mutations of Fus
lead to motor neuron degeneration in ALS. In this study, we present a Drosophila model to examine the toxicity of
Fus, its Drosophila orthologue Cabeza (Caz), and the ALS-related Fus mutants.
Results: Our results show that the expression of wild-type Fus/Caz or FusR521G induced progressive toxicity in
multiple tissues of the transgenic flies in a dose- and age-dependent manner. The expression of Fus, Caz, or
FusR521G in motor neurons significantly impaired the locomotive ability of fly larvae and adults. The presynaptic
structures in neuromuscular junctions were disrupted and motor neurons in the ventral nerve cord (VNC) were
disorganized and underwent apoptosis. Surprisingly, the interruption of Fus nuclear localization by either deleting
its nuclear localization sequence (NLS) or adding a nuclear export signal (NES) blocked Fus toxicity. Moreover, we
discovered that the loss of caz in Drosophila led to severe growth defects in the eyes and VNCs, caused
locomotive disability and NMJ disruption, but did not induce apoptotic cell death.
Conclusions: These data demonstrate that the overexpression of Fus/Caz causes in vivo toxicity by disrupting
neuromuscular junctions (NMJs) and inducing apoptosis in motor neurons. In addition, the nuclear localization of
Fus is essential for Fus to induce toxicity. Our findings also suggest that Fus overexpression and gene deletion can
cause similar degenerative phenotypes but the underlying mechanisms are likely different.
Keywords: ALS, Fus, Caz, Locomotion, Neurodegeneration, Drosophila

Background
Amyotrophic lateral sclerosis (ALS, also known as Lou
Gehrig’s disease) is a motor neuron disease that causes
a disabling condition whereby the degeneration of
motor neurons causes progressive muscle weakness and
leads to death usually within five years of disease onset
[1]. Most cases of ALS occur sporadically, however a
small percentage of cases are inherited. Several ALS
genes have been identified, and mutations within them
can lead to familial ALS [2], including Cu/Zn superoxide
dismutase (SOD1) [3], TDP-43 [4] and Fused in
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sarcoma (Fus) [5-8]. In addition to familial ALS, Fus
mutations are also implicated in sporadic ALS cases
[9-11]. Both Fus and TDP-43 are DNA- and RNA-binding proteins. While TDP-43 has been intensively studied, the role of Fus in the ALS etiology is largely
unknown.
Fus is a ubiquitous multi-domain RNA-binding protein [12] involved in many processes of RNA metabolism including transcriptional regulation, mRNA splicing
and mRNA shuttling between the nucleus and the cytoplasm [13,14]. In neurons, Fus is also implicated in the
transportation of mRNA for local translation in dendrites [15,16]. Fus mainly localizes in the nucleus, but
has also been shown to present at lower levels in the
cytoplasm of most cell types, including neurons and
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glial cells [17,18]. The ALS-related mutations are clustered in the carboxyl-terminus of Fus and exhibit an
abnormal nucleo-cytoplasmic redistribution and cytosolic inclusions in the motor neurons in familial ALS
patients [7,8]. Studies at the cellular level have shown
that the nuclear localization sequence (NLS) located in
the C-terminus of Fus is necessary and sufficient for
nuclear targeting of Fus [19]. ALS mutations within the
NLS significantly impair the nuclear targeting function
of the sequence, leading to the cytoplasmic accumulation of mutant Fus. Mutations in the NLS have also
been shown to promote Fus co-localization with stress
granules in the cytosol [19-21]. However, it is still
unclear how the mutations cause the toxicity. Moreover,
wild-type Fus aggregation has also been reported in several ALS cases. Thus, it is important to determine
whether the cytoplasmic or nuclear fraction of Fus is
critical to cause the toxicity in ALS. The tentative
hypothesis in the field is that cytoplasmic mislocalization and inclusions are important during the disease
process. However, this remains to be thoroughly tested.
Appropriately constructed animal models are valuable
for defining the link between gene mutations and the
ALS disease. Well-established genetics, small genome
size, minimal genetic redundancy, and ease of handling
have made Drosophila an ideal model system to study
conserved mechanisms that are involved in human diseases. Studies using Drosophila as a model have shown
that mutating TDP-43 causes locomotive defects [22],
whereas overexpressing TDP-43 causes neurotoxicity
[23], most likely through genetic interactions with
TER94, which is an ATPase associated with multiple
cellular activities [24]. These findings suggest that Drosophila is a powerful animal model for ALS. Studies of
transgenic Drosophila lines with the overexpression of
Fus have been reported in the past [25-27], but the
molecular mechanisms underlying Fus/Caz function in
Drosophila remain elusive. The Drosophila homologue
of Fus, Cabeza (Caz), is enriched in the brain and central nervous system [28,29]. However, the functional link
between Drosophila Caz and human Fus has not yet
been established.
In this study, we generated and characterized transgenic flies expressing wild-type Fus, several ALS-related
Fus mutants, and wild-type Caz using different tissuespecific Gal4 lines. We found that toxicity was dependent on the expression level of Fus/Caz in all tissues
examined. Flies overexpressing Fus or Caz by the motor
neuron-specific Gal4 showed significantly impaired larval crawling and adult fly movement. Defects in the
neuromuscular junctions (NMJs) were evident in these
flies. In addition, motor neurons in the ventral nerve
cord (VNC) of these flies were disorganized and showed
elevated apoptosis. More interestingly, C-terminal NLS
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is essential for Fus toxicity, since both the deletion of
the last 32 amino acids in Fus (FusΔ32) and the addition
of an NES to wild type full-length Fus (FusNES) dramatically reduced toxicity in vivo. Finally, we analyzed the
caz mutant flies and found that the loss of Caz induced
phenotypes in Drosophila eyes, VNC neurons, and
NMJs. The lack of Caz in motor neurons caused similar
NMJ defects and locomotive impairment as the Fus/Caz
overexpressing flies, but did not cause apoptosis in
motor neuron cell bodies. Thus, the mechanisms underlying the toxicity caused by Caz deletion and Fus/Caz
overexpression are likely different. The genetic model
we generated shows that Fus/Caz is required for neuronal function in vivo and that elevated levels of Fus/Caz
in the nucleus can induce neuronal toxicity. The findings of this study provide insights into the molecular
mechanisms of Fus/Caz in motor neuron degeneration
and ALS.

Results
The expression of Fus/Caz results in wing defects and
decreased viability in Drosophila

Animal models for neurodegenerative diseases often
involve overexpression of disease relevant proteins in
yeast, Drosophila, C. elegans, and mouse. We generated
transgenic flies with the PhiC31 integration system to
integrate human Fus or Drosophila homolog Caz cDNA
at the 75B1 attP locus in the Drosophila genome to
ensure that the proteins were expressed at the same
level without positional effects [30,31]. Using this precise
approach, we investigated the pathogenic properties of
human Fus and fly Caz in Drosophila. Individual Fus
variants were overexpressed in a tissue-specific fashion
using (i) a wing-specific MS1096-Gal4, (ii) a ubiquitous
act5C-Gal4 in all fly tissues, (iii) an embryonic nervous
system specific Elav-Gal4, and (iv) a larval and adult
motor neuron-specific D42-Gal4.
We first found that overexpressing Myc-tagged Fus
(Myc-Fus) or FusR521G mutant (Myc-FusR521G) using
MS1096-Gal4 interrupted wing growth (Figure 1B-C).
The ubiquitous overexpression of Fus severely reduced
adult viability at 25°C and 19°C (Figure 1G-H). Overexpressing Fus in neurons using Elav-Gal4 and D42-Gal4
also significantly reduced adult viability at 25°C (Figure
1G), but the adult viability improved at 19°C when the
Fus overexpression level was lower (Figure 1H). The
overexpression of Myc-FusR521C produced similar phenotypes to those caused by overexpressing MycFusR521G (data not shown). Surprisingly, we found that
expressing Myc-tagged Fus lacking the last 32 amino
acids of the NLS (Myc-FusΔ32) gave rise to a wild-type
wing (Figure 1D) and nearly 100% adult viability (Figure
1G-H). These data give the first indication that the Cterminal NLS is required for Fus toxicity in vivo.
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Figure 1 Overexpression of Fus/Caz produces phenotypes and induces growth defects in Drosophila. (A) A wild-type adult wing showing
intervein 1-5. (B-F) Adult wings expressing Fus, FusR521G, FusΔ32, Caz, or CazRNAi with UAS-Dicer by the wing-specific MS1096-Gal4. (G) Bar
graphs showing adult fly viability assayed at 25°C. (H) Bar graphs showing adult fly viability assayed at 19°C. Overexpressing the indicated
constructs by different Gal4 lines induces growth defects or lethality at larval or pupal stages. The # indicates lethality at either the larval or
pupal stages.
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Caz is the Drosophila homologue of Fus and has been
reported to be enriched in the brain and central nervous system [28,29]. Caz shares a similar domain structure with Fus (Additional file 1: Figure S1) and exhibits
51% identity to Fus in the C-terminal region containing
the RNA recognition motif and RGG domains. However, its in vivo function and its possible role in neurodegeneration are unclear. We examined the potential
role of Caz in neurodegeneration using overexpression,
RNAi knockdown, and knockout approaches in this
study. The overexpression of HA-tagged Drosophila Caz
(HA-Caz) caused similar phenotypes in the wing (Figure
1E) and even more dramatic decrease in adult viability
(Figure 1G-H). The native Caz protein may adopt a
more favorable condition in the flies and therefore
induce more severe toxicity compared to overexpressed
human Fus. These findings suggest that the overexpression of Fus or Caz had similar growth defects in flies.
Interestingly, the knockdown of Caz by RNAi affected
wing growth (Figure 1F) and reduced adult viability (Figure 1G-H), suggesting that endogenous Caz is involved
in Drosophila growth control. This provides initial evidence that Caz deletion can produce toxicity as well,
which was thoroughly examined in caz mutant flies later
in this study.
Over-expression of Fus/Caz in Drosophila eye induces
retinal degeneration

The Drosophila compound eye, which consists of
approximately 750 single eye units called ommatidia,
has been used as a model for studying human neurodegenerative disorders [32]. We used a GMR-Gal4 driver
to express Myc-Fus, FusR521G, FusΔ32, and HA-Caz in
Drosophila eyes. We found that the expression of Fus
(Figure 2B-C) or Caz (Figure 2H-I) caused severe eye
degeneration. The expression of FusR521G induced a
phenotype similar to that caused by Fus (Figure 2D-E).
We also examined eye structures of the frontal sections
using Eosin Phloxine staining. We found that the
ommatidia organization was completely lost in fly eyes
expressing Fus, FusR521G, or Caz (Figure 2K, L, and
2N, respectively), compared to eyes from control flies
that had an intact structure (Figure 2J). In contrast, flies
expressing FusΔ32 showed a nearly wild-type eye
(Figure 2F-G) and had little, if any, retinal degeneration
(Figure 2M).
We noted that expressing two copies of Fus or Caz
gave rise to more severe eye phenotypes than expressing
one copy (compare Figure 2C and 2I to Figure 2B and
2H, respectively). These observations suggest that the
toxicity and phenotypes are clearly dependent on Fus/
Caz expression levels in the Drosophila model system,
which supports the hypothesis that the deregulated
higher expression of Fus can be toxic. We further found
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that, in a time course experiment of fly eyes, the overexpression of these proteins produced a progressive eye
phenotype, with Caz being the most toxic protein in
eyes (Figure 2O-R) and suggesting that the retinal
degeneration was progressive with aging. Western blot
analysis was performed and confirmed that the proteins
were expressed at comparable levels (Additional file 1:
Figure S2). We also found that Myc-FusR521C had a
similar effect as Myc-FusR521G did (not shown). These
findings suggest that Fus/Caz induces toxicity in a doseand age-dependent manner.
We next systematically characterized the in vivo toxicity of various Fus mutations in different tissues using a
variety of Gal4 lines. Table S1 summarizes the results of
wing, eye, and adult viability results from the above Fus/
Caz constructs and two additional mutations. Sequence
analysis revealed a highly conserved tyrosine kinase
phosphorylation motif (RXXPY) in the C-terminus of
Fus/Caz, and mutation of the tyrosine residue in this
motif (FusY526F) significantly reduced the in vivo toxicity of Fus (Table S1). A consistent but striking finding
in these experiments is that the truncation mutation
FusΔ32 lacking the C-terminal NLS was largely nontoxic in all lines we tested. We generated a shorter truncation mutation of Fus lacking the RGG-rich domain in
the C-terminus (Fus1-453) and found that it was also
non-toxic and thus allowed full adult viability (Table S1,
data not shown).
The expression of Fus/Caz in motor neurons causes
locomotive impairment

We next characterized the locomotive function of the
flies overexpressing Fus, Fus mutants, or Caz. We used
another motor neuron-specific OK371-Gal4, which is
expressed earlier than D42-Gal4 in the larval stage.
When Fus, FusR521G, or Caz was overexpressed
through the OK371-Gal4 line, the locomotive ability of
third instar larvae was markedly impaired (Figure 3A).
The average moving distances also correlated with the
protein toxicity presented in Table S1. The Caz larvae
moved the shortest distance and the FusΔ32 larvae
moved the longest distance in a specific period of time
among the flies expressing different forms of Fus/Caz
(Figure 3A). A comparable level of protein expression in
larval brain extracts was confirmed by Western blot
(Figure 3B).
We further examined the locomotion of adult flies
expressing Fus, Fus mutants, and Caz. We used the
other motor neuron-specific Gal4 line, D42-Gal4, in the
adult movement assays because Fus, FusR521G, and Caz
expression by OK371-Gal4 caused pupal lethality. We
found that the locomotive ability of two-day-old flies
was severely impaired by the expression of Fus or
FusR521G but not by the expression of FusΔ32 (Figure
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Figure 2 Expression of Fus/Caz in fly eyes leads to progressive eye defects in a dose- and age-dependent manner. (A) A wild-type eye
showing the typical ommatidia structure. (B-I) Morphology of eyes expressing one or two copies of Fus, FusR521G, FusΔ32, or Caz by GMR-Gal4
at day 4 after adult hatching. Fus, FusR521G, and Caz expressing eyes exhibit ommatidia loss and necrotic lesions. (J) Retinal section of a wildtype fly eye stained with Eosin shows intact ommatidial and rhabdomere structure. (K-N) Retinal sections of eyes expressing two copies of Fus,
FusR521G, FusΔ32, or Caz by GMR-Gal4 at 4 DAE were stained with Eosin. Rhabdomere structures were disintegrated and ommatidia were
disorganized in eyes expressing Fus, FusR521G, or Caz, but not in eyes expressing FusΔ32. (O-R) Quantification of the eye defects when
expressing the indicated constructs during aging. Eye defects were classified in three levels: 1, < 30% ommatidia loss; 2, 30-70% ommatidia loss,
and 3, > 70% ommatidia loss. The percentages of flies with each level of eye defects are shown in different colors (1, green; 2, blue; 3, red). (S)
Western blots were performed with eye extracts from flies in Figure 2O-R at the indicated time points to monitor the levels of protein
expression. Each individual protein was expressed at the attP site of the 75B1 locus by GMR-Gal4 to ensure that the proteins were expressed at a
comparable level.
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Figure 3 The locomotive ability affected by the expression of different forms of Fus or Caz. (A) Expression of Fus/Caz in fly motor
neurons impairs the locomotive ability in larvae. A graph of the average moving distance of the third instar larvae traveling over 30 sec is
shown here (n = 15 male larvae scored for each group). Each larva was tested 3 times. The OK371-Gal4 was used for these experiments. (B)
Larvae brains with VNCs from experiments in A were subjected to Western blots with antibodies against the epitope tags to monitor the
comparable levels of protein expression. GFP serves as an internal protein expression and loading control. (C-D) Graphs of average climbing
distance of the adult flies at Day 2 or Day 10 after emergence. Each adult fly was placed at the bottom of a 2 ml pipette and allowed to climb
vertically for 30 s (n = 20 male flies for each group). Each fly was counted 3 times. The height that the flies climbed on the inside wall of the
pipette is an indication of their locomotion ability. The D42-Gal4 was used for these experiments. The “#” symbol indicates pupal lethality. The
larval locomotion was significantly impaired by Fus, FusR521G, and Caz expression, but not by FusΔ32 expression.

3C). Similar results were achieved by analyzing the tenday-old flies (Figure 3D). In this experiment, the expression of Caz by the D42-Gal4 caused pupal lethality, indicating that Caz induced severe toxicity (Figure 3C-D).
We also found that the expression of FusR521C produced a similar phenotype as that of FusR521G (data
not shown). Taken together, the locomotive defects
caused by Fus or Caz suggest that Fus/Caz is involved
in neurodegeneration after larval stage.

Overexpression of Fus/Caz disrupts presynaptic terminals
at the neuromuscular junction (NMJ) and causes
disorganization of motor neurons in larval ventral nerve
cord (VNC)

To gain more insights into the disease etiology, we analyzed the morphology of motor neuronal presynaptic
terminals at the NMJ in flies. Third instar larval muscle
fillets were dissected and double-labeled with an antiHRP antibody to visualize the neuronal membrane and
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an anti-Dlg antibody to mark the subsynaptic reticulum
surrounding each bouton. The expression of a membrane GFP (mGFP) by OK371-Gal4 was used to mark
the motor neurons and did not have any effect on bouton formation at NMJ (Figure 4A, F and 4I).
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Morphological abnormalities were found in larvae coexpressing mGFP with either Fus or Caz by OK371Gal4. As shown in Figure 4, the overexpression of Fus
substantially reduced the area (Figure 4B) and the number of both large and small boutons (Figure 4F and 4I).

Figure 4 The overexpression of Fus/Caz causes morphological and functional defects in NMJs. (A) A representative confocal image
(projection over the Z axis) of muscle 6/7 NMJs in the abdominal segment A2 of a third instar larva expressing mGFP by OK371-Gal4. The antiHRP antibody staining labels the neuronal membrane and the anti-Dlg antibody staining marks the subsynaptic reticulum surrounding each
bouton. (B-E) NMJs in the abdominal segment A2 from larvae coexpressing mGFP with Fus, FusR521G, FusΔ32, or Caz by OK371-Gal4 were
stained for Dlg, HRP, and Myc or HA with the appropriate antibodies. Branches and the number of large boutons revealed by Dlg staining were
dramatically reduced by Fus, FusR521G, and Caz, but not by FusΔ32 expression. (F) Quantification analysis of the large boutons in the NMJs from
ventral longitudinal muscles 6 and 7 of segment A2 (mean ± s.d.; n ≥ 20). OK371-Gal4 alone served as control. (G-H) Representative images of
axon branches and small boutons, as visualized by both mGFP and HRP staining, at muscle 6/7 NMJs in the abdominal segment A2. (I)
Quantification of the small boutons in the NMJs from ventral segment A2 (mean ± s.d.; n ≥ 20). OK371-Gal4 alone served as control.
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Compared to Fus, expression of Caz had more severe
NMJ defects (Figure 4E, F, H, and 4I). Interestingly,
overexpression of FusΔ32 induced little, if any, disruption in the presynaptic terminals (Figure 4D, F, and 4I).
These findings are consistent with the locomotive deficiency observed in the animals (Figure 3C-D), suggesting that the abnormal NMJs in flies expressing Fus are
responsible for the impaired motor function. The results
are also consistent with the toxicity of Fus/Caz observed
in other tissues (Additional file 1: Table S1).
To further elucidate whether Fus overexpression
caused any defects in motor neuron cell bodies, we next
examined the motor neurons in larval ventral nerve
cord (VNC) from late third instar larvae expressing different Fus/Caz proteins by the OK371-Gal4. Motor neurons in the ventral clusters are well-organized in the
larval VNC in wild-type flies (Figure 5A). In addition,
longitudinal motor neurons, which ensheath the cortex
of the VNC, are logitudinally connected, and the segmental nerve of the abdominal neuromeres A1-A5 are
well-organized in wild-type flies (Figure 5B). As
expected, we found that the OK371-Gal4-mediated
expression of Fus, FusR521G, or Caz induced disorganized motor neurons in A1-A5 of the larval VNC (Figure 5C, D, and F). In contrast, the overexpression of
FusΔ32 again had no effect on the organization of neuromeres A1-A5 (Figure 5E), which was consistent with
the finding that this truncation mutant had no toxicity
in motor neurons (Figures 3 and 4).
To solidify the relationship between nuclear localization and toxicity, we constructed Myc-tagged FusNES
with a typical nuclear export signal (NES) fused in
frame to the C-terminus of FUS (Myc-FusNES) and
Myc-tagged chimeric FusΔ32NLS with the NLS of
another RNA binding protein hnRNP D fused to the Cterminus of FusΔ32 (Myc-FusΔ32NLS). We then generated transgenic lines at the 75B1 - VK5 attP locus.
Expression of FusNES by the OK371-Gal4 had markedly
less effect in larva VNC (Figure 5G) and did not induce
locomotive defects in the third instar larvae (Figure 5I).
Thus, both FusΔ32 and FusNES were largely non-toxic
in a similar fashion. In contrast, expression of
FusΔ32NLS induced disorganization of motor neurons
in VNC (Figure 5H) and caused locomotive defects at a
comparable level as in flies expressing Fus (Figure 5I).
We also found that FusNES did not cause any phenotype in the eyes or NMJs when driven by GMR-Gal4 or
OK371-Gal4, whereas FusΔ32NLS did (Table S1).
We examined the subcellular localization of Fus/Caz
proteins using confocal microscopy. Consistent with our
previous findings in mammalian cells [19], we found
that Fus, Caz, and FusΔ32NLS were largely localized
in the nuclei of motor neurons in the VNC (Additional
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file 1: Figures S2A and S2D). There was a small increase
in cytoplasmic staining of FusR521G (Additional file 1:
Figure S2B), whereas FusΔ32 and FusNES were largely
cytosolic (Additional file 1: Figure S2C and S2E). Taken
together, the data from all tissues examined (Figures 1,
2, 3, 4) suggest that the toxicity of Fus/Caz in flies is
likely due to, at least in part, the abnormal function
caused by the nuclear fraction of Fus/Caz protein.
The expression of Fus/Caz induces apoptosis in motor
neurons

In the above experiment, we observed an abnormal
nuclear structure in motor neurons overexpressing Fus/
Caz when the cells were stained with Hoechst 33342
nuclear dye. Motor neuron cells expressing the mGFP
alone showed a normal even nuclear staining (arrow in
Figure 6A), which was almost identical to the structure
of the adjacent non-motor neuronal cells (arrowhead in
Figure 6A). Surprisingly, the overexpression of Fus or
Caz with mGFP resulted in decreased nuclear staining
reminiscent of apoptotic bodies in the GFP-positive
motor neurons (arrows in Figure 6B and 6E). In contrast, the nuclear staining was largely uniform in the
adjacent non-Fus/Caz-expressing cells (arrowheads in
Figure 6B and 6E). Consistent with the earlier data, the
expression of FusR521G gave rise to a similar effect to
that of Fus (arrow in Figure 6C). The expression of
FusΔ32 and FusNES gave rise to normal nuclear staining in motor neurons (arrows in Figures 6D and 6E),
whereas FusΔ32NLS induced abnormal nuclear staining
(arrow in Figure 6G). These data again suggest that the
toxicity of Fus/Caz is caused, at least in part, by the protein localized in the nucleus.
We next performed the terminal deoxynucleotodyl
transferase dUTP nick end labeling (TUNEL) assay to
examine whether the expression of Fus/Caz could induce
apoptosis in the VNC. We did not detect any TUNELpositive cells in control third instar larval VNC (Figure
6H). However, Fus expression in VNCs led to approximately 20-30 TUNEL-positive cells in the same larval
stage (Figure 6I), suggesting that overexpression of Fus
induced neuronal apoptosis in the VNC. In contrast, the
overexpression of FusΔ32 or FusNES did not give rise to
TUNEL-positive cells (Figure 6J, not shown), which was
consistent with the finding that FusΔ32 and FusNES
induced little disorganization of motor neurons in the
VNC. In addition, we found that the overexpression of
Caz induced approximately 40-50 TUNEL-positive cells
in the VNC (Figure 6K), which could explain why the
overexpression of Caz at an equivalent level as Fus led to
a more severe toxicity. Our results suggest that the neurodegeneration induced by Fus/Caz overexpression
occurs due to apoptosis in the Drosophila VNC.
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Figure 5 The expression of Fus/Caz disrupts the arrangement of motor neurons in the VNC. (A) A VNC from the third instar larva
expressing mGFP by OK371-Gal4 was stained with nuclear dye Hoechst 33342 (blue NU signal). The GFP signal indicates intact motor neurons.
T1-T3 indicates the three thoracic neuromeres and A1-A8 indicates the eight abdominal neuromeres. (B) Shown here are the well-organized
segmental motor neurons of the abdominal neuromeres A1-A5. The organization of motor neurons is used as a model to examine the neuronal
toxicity of Fus/Caz in this study. (C-E) VNCs from third instar larvae co-expressing mGFP with Myc-tagged Fus, FusR521G, or FusΔ32 by OK371Gal4 were stained with an anti-Myc antibody and Hoechst. Fus and FusR521G disrupted the organization of motor neurons in A1-A5
neuromeres, but FusΔ32 did not. (F) A VNC from larva coexpressing mGFP with HA-Caz was stained with an anti-HA antibody and Hoechst
33342. The expression of Caz severely disrupted the arrangement of motor neurons in A1-A5 neuromeres. (G-H) VNCs from larvae coexpressing
mGFP with Myc-FusNES or Myc-FusΔ32NLS were stained with the anti-Myc antibody and Hoechst 33342. (I) A graph of the average moving
distance of the third instar larvae expressing the indicated proteins and traveling over 30 sec (n = 15 male larvae scored for each group). Each
larva was tested 3 times. The OK371-Gal4 was used as the driver.
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Figure 6 Neurodegeneration induced by Fus/Caz overexpression occurs due to apoptosis. (A) A large magnification of the VNC from a
third instar larva expressing mGFP by OK371-Gal4 shows GFP-labeled motor neurons and adjacent non-motor neuronal cells. Arrows in A
indicate the nuclear structure of motor neuronal cells and arrowheads indicate the nuclear structure of adjacent cells. (B-G) VNCs from larvae
coexpressing mGFP with Myc-Fus, Myc-FusR521G, HA-Caz, Myc-FusNES, or Myc-FusΔ32NLS were stained with the indicated antibodies and the
Hoechst 33342 dye to label the nuclear structures. Arrows in B, C, E, and G indicate the decreased nuclear staining and disrupted nuclear
structure by the expression of Fus, FusR521G, Caz, or FusΔ32NLS in the nuclei. Arrows in D and F indicate the unaffected nuclear structures. The
arrowheads indicate the nuclear staining of normal adjacent cells, which serves as a control. (H-K) TUNEL assays were performed on the VNC
from the larvae of OK371-Gal4 (control) or the larvae expressing Fus, FusΔ32, or Caz by OK371-Gal4. Apoptotic cell death is measured by the
TUNEL signal (green).
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The phenotypes of caz deletion mutant Drosophila

consistent with the findings in fly locomotive function
rescue from a previous study [27]. These results suggest
that Caz is required for the function of photoreceptor
neurons as well as motor neurons.
We further assessed the organization of the motor
neurons in VNC in caz mutant flies as we did in the
Fus/Caz overexpressing flies. We found that caz mutant
male flies exhibited disorganized motor neurons in neuromeres A1-A5 of the VNC (Figure 7N), a phenotype
similar to that caused by the overexpression of Fus/Caz
(Figure 5C and 5F). However, unlike the Fus/Caz overexpression flies, loss of caz did not cause any decrease
in nuclear staining by Hoechst 33342 (arrow in Figure
7O). Mutating caz in the motor neurons also did not
produce any TUNEL-positive cells in the VNC (Figure
7P). These results suggest that the loss of caz did not
promote cell death of motor neurons although it disrupted NMJs and impaired locomotive function in the
caz mutant flies. Consistent with these results, Caz
RNAi also interrupted the arrangement of motor neurons in VNCs (Figure 7R), but did not cause any
decrease in nuclear staining (Additional file 1: Figure
S7) or any TUNEL-positive cells (not shown). Collectively, these data suggest that the mechanism underlying
the phenotypes in the caz mutant line is different from
that in the Fus/Caz overexpression flies.

Our initial study of caz inactivation in flies using the
RNAi lines from the Vienna Drosophila RNAi Center
(VDRC) found that CazRNAi caused a defective morphology in the wing (Figure 1F) and reduced the viability of adult flies (Figure 1G-H). Next, we explored the
neuronal function of Caz by analyzing caz mutant phenotypes. A deficiency line DF(1)BSC759, which harbors
a deletion in caz and other genes upstream of caz, was
first used. DF(1)BSC759 heterozygous females exhibited
wild-type eyes with the balancer marker (Figure 7B), but
DF(1)BSC759 homozygous females were lethal at the
pupa stage and the adult escapers exhibited loss of
ommatidia in the eyes (Figure 7C and Additional file 1:
Figure S3C). DF(1)BSC759 males also showed a similar
eye phenotype (Figure 7E and Additional file 1: Figure
S3E). These data suggest that the lack of Caz disrupts
the formation of Drosophila ommatidia. Another deficiency line DF(1)ED7355, which retains the wild-type
caz gene but lacks a fragment upstream of caz, was able
to suppress the eye phenotypes in the complementary
test. The results suggest that the phenotype in DF(1)
BSC759 was caused by the loss of caz but not other
genes. We also examined the other caz mutant allele
caz1 [27] and found that caz1 mutant had similar phenotypes as DF(1)BSC759.
We next examined how caz deletion caused the
degenerative phenotypes in eyes as seen in the caz
homozygous flies (Figure 7C’, compared to Figures 7A’
and 7B’). An anti-HRP antibody was used to detect the
photoreceptor neurons and an anti-Elav antibody to
detect the pan neurons in third instar larvae. The Elav
signal was evenly distributed in the well-organized
ommatidia units of eye discs in the wild-type (Figure
7F-F’) and caz heterozygous female (Figure 7G-G’) flies.
In contrast, the eye discs from caz/caz homozygous
female (Figure 7H-H’) and caz/y male (Figure 7I-I’) flies
showed a substantially decreased Elav staining with
abnormal puncta in disorganized ommatidia. In addition, Caz knockdown by RNAi also disrupted ommatidia
formation (Figure 7Q). These data suggest that Caz is
required for maintaining normal function of the neurons
in the eye.
We next assessed the function of Caz in Drosophila
motor neurons. Loss of caz in motor neurons significantly impaired the locomotive ability of adult flies of
both males and females (Figure 7J) and shortened the
lifespan of adult flies (data not shown). Male caz mutant
larvae showed severe reduction in locomotive activity
(Figure 7K). Examination of the NMJs in the male
mutant larvae revealed a severe decrease in numbers for
both big and small boutons in the NMJs (Figure 7L-M).
The eye phenotype was fully rescued by expressing
wild-type Fus or Caz (data not shown), which is

Discussion
The vast majority of the molecules critical to neuronal
function are conserved between Drosophila and more
complex vertebrate systems, thus Drosophila is a powerful model to study neurodegenerative diseases including
ALS. In this study, we showed that the overexpression
of human Fus as well as the Drosophila homolog Caz
caused neuronal toxicity in vivo in all Gal4 lines that we
tested, including ubiquitous expression (act5C-Gal4),
wings (MS1096-Gal4), eyes (GMR-Gal4), neurons (ElavGal4) and motor neurons (D42- and OK371-Gal4).
Since Fus/Caz protein was expressed at late larval or
pupal stages and the degenerative phenotypes were progressive with aging, the Fus/Caz overexpressing flies are
a reasonably good model to study the relevance of Fus
in motor neuron degeneration in ALS. Furthermore, we
provide evidence that both loss of Caz and overexpression of Fus/Caz can induce phenotypic defects although
the underlying cellular mechanisms are likely to be different in these two models.
Nuclear toxicity of Fus/Caz in the absence of cytoplasmic
inclusions

It has been recently shown that the overexpression of
Fus in flies leads to neuronal toxicity [25-27]. However,
it is unknown whether overexpression of Drosophila
Caz can cause toxicity. In this study, overexpression of
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Figure 7 The loss of caz leads to neuron functional defects in Drosophila. (A-A’) An eye from yw female flies showing wild-type ommatidial
and rhabdomere structure. (B-B’) An eye from caz heterozygous female flies shows the balancer marker and intact ommatidial and rhabdomere
structure. (C-C’) An eye from caz homozygous female fly shows the loss of ommatidia and the disrupted rhabdomere structure. (D) An eye from
yw male fly showing normal ommatidial. (E) An eye from caz mutant male showing the loss of ommatidia. (F-F’) A wild-type eye imaginal disc
from the third instar larvae was stained for Elav and HRP to show the well-developed and well-organized structure of the ommatidia units. (G-H’)
Eye discs from either caz heterozygous or homozygous female third instar larvae were immunostained for Elav and HRP. (I-I’) An eye disc from
caz male larva was stained for Elav and HRP. (J) A graph of the average climbing distance of caz mutant adult flies at Day 2 after emergence.
The same method was used as in Figure 4. N = 20 flies for each genotypic group. (K) A graph of the average moving distance of the third instar
larvae of caz males traveling over 30 s (n = 15 male larvae scored for each group). Each larva was tested 3 times. (L-M) Quantification analysis of
the large and small boutons in the NMJs from ventral longitudinal muscles 6 and 7 of segment A2 in caz mutant male larvae (mean ± s.d.; n ≥
20). (N) A VNC from a caz mutant male fly expressing mGFP by OK371-Gal4 shows the disrupted motor neuron organization in A1-A5
neuromeres. (O) A large magnification image from N. The arrow indicates the motor neuron nuclear staining, which is similar to the nuclear
staining of an adjacent cell (arrowhead). (P) TUNEL assay was performed on VNC from the larvae of a caz/+ female, caz/caz female, and caz
male. A representative TUNEL image from the VNC of a caz male is shown here. None of the caz mutant larvae showed TUNEL-positive cells. (Q)
An eye imaginal disc expressing Dicer and CazRNAi by GMR-Gal4 was stained for Elav and HRP. (R) A VNC from a third instar larva coexpressing
mGFP with Dicer and CazRNAi shows the disorganization of motor neurons in A1-A5 neuromeres. (S) A large magnification image from R. The
arrow indicates the motor neuron nuclear staining, which is similar to the nuclear staining of an adjacent cell (arrowhead).
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fly Caz caused similar or even more severe toxicity in all
experiments compared to overexpression of human Fus
(Figures 1, 2, 3, 4). This is reminiscent of the studies of
another ALS-implicated RNA binding protein TDP-43
that the overexpression of TDP-43 was shown to be
toxic in yeast [33], Drosophila [23,24,34,35], C. elegans
[36], and mouse [37,38]. It is noted that protein inclusions of wild-type Fus have also been reported in
human ALS patients [7,8]. These findings underscore
the importance of understanding the underlying molecular mechanisms of Fus in ALS.
Our group and others have shown that the last 32
amino acids of the protein contain an NLS that is both
essential and sufficient for nuclear targeting. It has also
been shown that the ALS-related mutations in Fus
increased the cytoplasmic localization of the protein and
promoted the co-localization of Fus with stress granules
in the cytosol [19-21]. However, the cytoplasmic accumulation may not be essential or sufficient for the toxicity observed for the protein [39,40]. Thus, the link
between toxicity and subcellular localization of Fus
needs to be characterized in vivo.
A novel finding of this study is that Fus nuclear localization is required for its toxicity in Drosophila. The
overexpression of FusΔ32 at comparable levels consistently showed little or no toxicity in all tissues. The in
vivo subcellular localization of wild-type Fus, R521G
mutant and FusΔ32 was confirmed to be consistent
with the findings in cell culture, i.e. FusΔ32 was largely
diffused outside of the nucleus. Moreover, the fusion of
an NES at the C-terminus of the full-length wild-type
Fus dramatically reduced toxicity in vivo (Figures 5G, I
and 6F). FusNES was also diffused in the motor neurons
(Additional file 1: Figure S2), thus the data from both
FusNES and FusΔ32 suggest that the nuclear localization is critical to the toxicity. Furthermore, the chimeric
protein FusΔ32NLS with an exogenous NLS was localized in the nucleus (Additional file 1: Figure S2) and
produced similar toxicity as wild-type Fus (Figure 5H, I,
and 6G). All these results consistently suggest that the
nuclear localization is required for Fus toxicity.
This surprising result differs from the common presumption that the toxicity is caused by the cytoplasmic
accumulation of Fus. Our study is the first one characterizing transgenic flies expressing truncated Fus mutant
with a primarily cytoplasmic localization. We further
manipulated the subcellular localization by using a typical NES and the other different NLS. All experiments
consistently support the conclusion. Interestingly,
another study showed that mutation in the NLS of
TDP-43 relieved the toxicity in C. elegans [36], supporting the conclusion of our study. However, the study by
Lanson et al. employed another approach by deleting a
postulated NES within the RNA recognition motif of
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Fus and showed reduced toxicity [25]. It should be
noted that Lanson et al. did not characterize the NES or
the subcellular localization of the NES deletion mutant.
Moreover, the postulated NES is within the RNA binding domain in Fus, therefore such deletion may cause a
disruption of the RNA binding properties of Fus. Thus,
the mechanism of the reduced toxicity of that particular
NES deletion mutant needs to be better elucidated. We
are confident in our conclusion since the results using
three different approaches (FusΔ32, FusNES, and
FusΔ32NLS) consistently support the requirement of
nuclear localization for Fus toxicity.
Another critical difference between this study and the
study by Lanson et al. is how the transgenic flies were
generated. The site-specific transgenic approach using
the integrase-mediated insertion at the specific attP
locus allowed us to ensure equal expression of the Fus
proteins without positional effects. We think that the
discrepancy is likely due to the expression level of the
protein. This likely explains the discrepancy regarding
the toxicity of the Fus transgene in different studies.
The R521G mutation produced comparable levels of
toxicity as wild-type Fus whereas the other study
showed more severe toxicity in flies expressing R521H
or R521C [25]. The experiments in our study are more
likely to produce comparable expression levels of the
Fus transgene since transgene insertion was random in
other studies.
Disruption of muscle 6/7 NMJs was observed in the
Fus transgenic flies in this study. It is important to note
that NMJ vulnerability occurs selectively in different
subgroups of motor neurons or muscles. The diversity
of subtypes of motor neurons and muscles and their
susceptibility are well documented in ALS [41]. We
examined the muscle 6/7 NMJs in the abdominal segment A2 of the third instar larvae, which is widely used
in Drosophila studies. In addition, we used GFP as a
marker to monitor the target protein expression. Our
results showed the expression of Fus/Caz in the disrupted NMJs. Studies characterizing NMJs in other
muscles may obtain different results, for example
another study examined muscle 4, segment A2 and 3
and did not observe reduction of synaptic boutons in
Fus overexpressing flies [25].
Notably, neither wild-type Fus/Caz nor the ALS mutants
of Fus showed cytoplasmic inclusions in transgenic flies
where severe toxicity was demonstrated in this study. The
results suggest that the cytoplasmic inclusions are not
essential to Fus toxicity although they have been prominently observed in cell culture systems and in human
patient tissues. It has long been proposed that soluble oligomers may be the culprit species causing neurodegenerative disease. A recent study showed that aberrant high
molecular weight complex of TDP-43 was toxic, although
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the nature of the species was still unknown [42]. A recent
study also showed that Fus toxicity could be suppressed
without eliminating protein inclusions in yeast [40], suggesting that protein inclusions might be a non-toxic and
non-essential feature of the disease.
Although the results in this study consistently suggest
that sufficient steady-state levels of Fus/Caz are required
for the toxicity and neurodegenerative phenotypes, it is
noted that Fus/Caz undergoes dynamic trafficking in
and out of the nucleus in live cells. It remains possible
that Fus/Caz with steady-state nuclear localization could
produce detrimental effect while it is temporarily outside of the nucleus. Alternatively, the minute amount of
Fus/Caz in the cytoplasm that cannot be detected by
confocal microscope could also produce cytosolic toxicity. We believe that these two are remote possibilities,
however additional studies using more sophisticated
approaches are needed to test them in the future. Moreover, the exact nature of Fus toxicity in the nucleus also
remains to be determined in future studies.
The phenotypes of caz deletion in Drosophila

Deletion of a specific gene provides insight into understanding the in vivo function of the protein. By taking
advantage of the Drosophila model, we found that endogenous Caz is required for normal functions of the neurons (Figure 7). The deficiency of caz in flies induced a
strong eye phenotype with disrupted ommatidia structure (Figure 7A-I) and caused defects in the locomotive
function in larvae (Figure 7K) and adult flies (Figure 7J).
Consistently, caz1 mutant flies exhibited decreased adult
viability and diminished locomotive activity [27]. These
phenotypes were actually similar to those caused by
Fus/Caz overexpression. It would be interesting to
examine whether some cases of ALS disease may be
caused by Fus loss-of-function in patients.
Given the motor deficiencies of Fus overexpression
and mutant caz flies, the presynaptic structure in NMJ
was examined. As expected, the number of boutons was
significantly reduced in the larvae overexpressing Fus
(Figure 4) as well as in the larvae lacking caz (Figure
7L-M). Thus the disruption of NMJ was evidently the
cause of the locomotive defects. Therefore, the Fus/Caz
overexpression and loss of caz obviously caused similar
disruption of presynaptic terminals in NMJs. It is likely
that Caz is required for neuronal function and therefore
the lack of Fus/Caz perturbs the motor neuron distal
terminus and causes NMJ disruption.
Different molecular mechanisms for degenerative
phenotypes in Fus overexpression and caz deletion
Drosophila

By examining the nuclear structure and monitoring apoptosis of cells in the VNC, we found that overexpression of
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Fus/Caz induced apoptotic cell death (Figure 6). However,
neither the caz deficiency (BSC759) nor the caz1 mutation
led to apoptosis (Figure 7P and 7S, data not shown).
Despite the critical difference, both Fus/Caz overexpression and caz deletion disrupted the NMJs. This raises the
question of where the toxicity originates, either from the
death of neuronal cell bodies or disruption of the NMJs.
Studies in the SOD1 mutant-mediated familial ALS
have suggested an axon die-back model in which perturbation at the distal NMJs occurs prior to the death of
motor neurons [41]. The Fus/Caz overexpression phenotypes support this model, but the time sequence of the
NMJ disruption and motor neuron death has not been
distinguished in these flies as yet. Moreover, both the
caz deficiency and caz1 mutant flies strongly support
this model since loss of Fus/Caz caused NMJ disruption
and motor function deficiency without the presence of
motor neuronal cell death. The findings in our study
support two potential mechanisms for the Fus/Caz
mediated neurotoxicity: neuronal apoptosis and NMJ
perturbation. These two mechanisms are not necessarily
mutually exclusive, and in fact may occur simultaneously. Further studies exploring of the in-depth
mechanisms by which Fus/Caz causes alterations in
RNA processing and nuclear toxicity are currently
ongoing. Many laboratories in the field also use various
models, including yeast [39,40,43,44] and Drosophila
[25-27], to investigate the role of Fus in RNA metabolism and the genetic interactions between Fus and other
RNA processing proteins. The overexpression and deletion Drosophila models in this study provide valuable
insight into the etiology of ALS and potentially other
degenerative diseases in which RNA processing proteins
are implicated.

Conclusions
We conclude from our study that the expression of Fus
can cause nuclear toxicity, induce apoptosis and facilitate NMJ perturbation in the transgenic Drosophila
model of ALS. Generation and characterization of the
Drosophila model of Fus-mediated ALS have revealed
several novel findings and provided new insights into
the disease etiology. There are three major novel findings in this study: (1) the C-terminus of Fus is essential
for its in vivo toxicity, suggesting that Fus toxicity originates from the nuclei instead of the cytoplasm; (2) both
the overexpression of Fus/Caz and the deletion of caz
caused similar deficiency in locomotive function and
disruption in NMJs; (3) the overexpression of Fus/Caz
induced apoptosis in motor neuron cell bodies, whereas
no apoptosis was observed in the motor neurons of the
caz mutant flies. In addition to the novel findings, we
have also developed assays to investigate the functions
of Fus/Caz in the Drosophila VNC. The novel neuronal
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functions of Caz that we have uncovered here are likely
to be conserved in other species.

Methods
Constructs, mutants, and transgenes

UAST-Myc-Fus was generated by subcloning the cDNA
fragment of human Fus into the attB-UAST-5xMyc vector. Amino acid substitutions of R521G, R521C, and
Y526F were generated by PCR-based site-directed mutagenesis. FusΔ32 and Fus1-453 were generated by truncation at F494 and G453, respectively. FusR521G,
FusR521C, FusY526F, Fus1-453, and FusΔ32 were subcloned into attB-UAST-5xMyc using the same approach
as used for Fus. To generate FusNES, the typical NES
sequence (NINELALKFAGLDI) [45] was fused in frame
with the C-terminus of Myc-Fus. To generate
FusΔ32NLS, the NLS sequence (YGDYSNQQSGYGKVSRRGGHQNSYKPY) from hnRNP D [46] was
fused in frame with FusΔ32. To generate HA-tagged
Caz (HA-Caz), we obtained cDNA clone (LD22761)
from the Drosophila Genome Resource Center (DGRC,
USA) and subcloned the full-length Caz cDNA into
attB-UAST-HA vector. To ensure that the proteins were
expressed at the same level without a positional effect,
the PhiC31 integration system was used to integrate Fus
and Caz transgenes into the 75B1 attP locus in the fly
genome [30,31]. The Caz RNAi line, v100291, and the
UAS-Dicer lines were obtained from the VDRC (Austria). DF(1)BSC759 and DF(1)ED7355 were obtained
from the Bloomington Drosophila Stock Center (USA).
caz1 mutant flies carry deletion Df[1]383 and a genomic
transgene for CG32576, which is supposed to be a caz
null [27]. MS1096-Gal4; D42-Gal4, Elav-Gal4, act5CGal4, GMR-Gal4, OK371-Gal4, UAS-Dicer, and yw have
been previously described (Flybase) [31].
Adult eye histology, immunoblot analysis, and eye
imaginal disc immunostaining

To analyze the internal structure of adult eyes, the heads
of flies from specific genotypes at 4 day-after-eclosion
(DAE) were fixed in Bouin’s fixative solution (Cat#
HT10132, Sigma, USA) for 48 h at room temperature on a
shaker at low speed, incubated 24 h in 50 mM Tris/150
mM NaCl, and then embedded in paraffin. Serial sections
(5 μm thickness) were taken through the entire head,
stained with Eosin (Cat# S176, Poly Scientific, USA), and
examined under a Leica DM750 microscope (Leica, Germany). Western blot was performed to confirm comparable levels of protein expression. Fifteen heads from adults
expressing different Fus or Caz transgenes by GMR-Gal4
were dissected and subjected to direct Western blot with
mouse anti-Myc (9E10, 1:5000, Santa Cruz, USA) and
anti-b-tubulin (1:5000, Developmental Studies Hybridoma
Bank; DSHB, USA). A standard protocol was used for the
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eye imaginal disc immunostaining assay. Eye discs were
dissected, fixed in 4% paraformaldehyde, washed in phosphate-buffered saline with 0.3% Triton-X100 (PBT), and
then stained with mouse anti-Elav (1:50, DSHB) for 2 h at
room temperature. After washing with PBT, the eye discs
were stained with goat anti-mouse Rhodamin (1:500, Jackson ImmunoResearch, USA) and rabbit anti-Horseradish
Peroxidase (HRP) conjugated to Cy5 (1:500, Jackson
ImmunoResearch) for 2 hours at room temperature.
Dissection, immunostaining, and analysis of NMJs from
third instar larvae

Late third instar larvae were dissected, fixed in 4% paraformaldehyde, washed in PBT, and stained with an antiDiscs-large (Dlg) antibody (1:100, DSHB) at room temperature for 2 h. After washing with PBT, the discs were
stained with goat anti-mouse Rhodamin (1:500, Jackson
ImmunoResearch) and rabbit anti-HRP antibody conjugated to Cy5 (Jackson ImmunoResearch, 1:500). Samples
were then mounted and viewed with an Olympus confocal microscope. Z-scan sections of the NMJs from ventral longitudinal muscles 6 and 7 at segment A2 were
taken at 1.0 μm intervals by confocal imaging (Olympus
Fluoview, Ver.1.7c) to visualize the HRP-positive neuronal membrane and the Dlg-positive large boutons. The
number of large and small boutons was also quantified
after intensity projection over the Z axis.
Immunostaining and TUNEL assay of the VNCs from third
instar larvae

Fly larval VNCs with brains from specific genotypes
were dissected, fixed in 4% paraformaldehyde, and
immunostained with mouse anti-Myc (9E10, 1:50, Santa
Cruz) or anti-HA (F-7, 1:150, Santa Cruz) for 2 h at
room temperature. After washing with PBT, the tissues
were stained with goat anti-mouse Rhodamin (1:500,
Jackson ImmunoResearch). Hoechst dye 33342 (1 μg/ml,
Invitrogen, USA) was added with the secondary antibody staining. For TUNEL staining, samples were pretreated with 3 μg/ml Proteinase K for 10 min at room
temperature, fixed in 4% paraformaldehyde, and permeabilized in PBT with 0.1% sodium citrate. Samples
were then treated with TUNEL (In Situ Cell Death
Detection Kit) with green fluorescence (Roche, Cat#
11684795910) followed by imaging analysis with the
Olympus confocal microscope.
Western blot was performed to confirm protein
expression at a comparable level. Five brains containing
VNCs from larvae expressing Fus variants or Caz by
OK371-Gal4 were dissected and lysed in regular Schneider S2 cell lysis buffer, and then subjected to direct
Western blot with mouse anti-Myc (9E10, 1:5000, Santa
Cruz), anti-HA (F-7, 1:1500, Santa Cruz), or anti-GFP
(1:1000, Millipore, USA).
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Larval movement and adult climbing assays

Third instar larvae bearing specific genotypes were subjected to motor function analysis on 100 mm agar plates.
Individual larvae were placed on plates and stimulated to
move with a needle. The distance they traveled over the
next 30 s was traced and measured. Each individual larva
was counted 3 times and 20 larvae were tested for each
group. The climbing ability of adult flies with different
genotypes was examined in empty 2 ml pipettes vertically.
Flies were first placed at the bottom of the pipette and the
climbing distances were scored over 30 s. Each fly was
recorded 3 times and 20 flies in each group were tested.

Additional material
Additional file 1: Figure S1 The caz gene encodes the Drosophila
homolog of Fus. A sequence alignment between Caz, mouse Fus, and
human Fus is shown here. The SYQG domain, G-rich domain, RNA
binding domain, Zn-finger domain, and RGG-rich domains are
underlined. The asterisks indicate the ALS-related mutations that occur in
patients. Additional file 1: Figure S2 Large magnification of the motor
neuronal cells indicating the localization of the proteins expressed in
VNCs from Figure 5. Fus, Caz, and FusΔ32NLS are exclusively localized in
the nucleus. FusR521G shows slightly increased staining in the cytosol,
but FusΔ32 and FusNES are mainly localized in the cytoplasm. Additional
file 1: Figure S3 Mutating caz in flies causes severe defects in the eye. (A)
A female yw fly showing adult wild-type morphology. (B) A caz
heterozygous female fly shows the balancer marker and intact eye
structure. (C) A caz homozygous female fly shows growth defects in the
eye and exhibits a normal body. (D) A male yw fly showing adult wildtype morphology. (E) A caz mutant male fly shows growth defects in the
eye and exhibits a normal body. Mutating caz causes severely disrupted
locomotive ability (Figure 7) without obvious changes in body size,
suggesting that Caz is likely involved in neurodegeneration. Additional
file 1: Table S1 Characterization of Fus toxicity in Drosophila. Shown here
is a diagram illustrating the domain structure of Fus along with
truncation and point mutation constructs that are expressed in flies by
the indicated Gal4 lines. The levels of toxicity are determined in the wing
(by MS1096-Gal4), the eye (by GMRGal4), the entire body (by the act5CGal4), and the neuron (by Elav-Gal4 and D42-Gal4). More “+” symbols
indicates more severe phenotypes.

Abbreviations
ALS: Amyotrophic lateral sclerosis; Fus: Fused in sarcoma; Caz: Cabeza; VNC:
Ventral nerve cord; NLS: Nuclear localization sequence; NES: Nuclear export
signal; SOD1: Cu/Zn superoxide dismutase; NMJ: Neuromuscular junction.
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